SEATTLE, April 9 /PRNewswire-FirstCall/ --
Immunex Corporation (Nasdaq: IMNX) will release first quarter 2002 financial
results on Monday, April 22, 2002, after the close of U.S. financial markets.
This announcement will be made available on the Immunex website at
http://www.immunex.com, and on PRNewswire's website at
http://www.prnewswire.com.
Additionally, Immunex executives will host a conference call and live
audio webcast at 2:00 p.m. PDT (5:00 p.m. EDT) on April 22nd to discuss the
company's financial results. The dial-in number for the earnings call is
719-457-2622 (ask for the Immunex call). The live webcast and replay can be
accessed on the Immunex website at http://www.immunex.com/investor_fs3.html .
Replay of the webcast will be available through April 28, 2002.
Immunex Corporation is a leading biopharmaceutical company dedicated to
improving lives through immune system science innovations.
NOTE: Except for the historical information contained herein, this news
release contains forward-looking statements that involve substantial risks and
uncertainties. Among the factors that could cause actual results or timelines
to differ materially are risks associated with research and clinical
development, regulatory approvals, our supply capabilities and reliance on
third-party manufacturers, product commercialization, competition, litigation
and other risk factors listed from time to time in reports filed by Immunex
with the SEC, including but not limited to risks described under the caption
"Important Factors That May Affect Our Business, Our Results of Operations and
Our Stock Price" within our most recently filed Form 10-K. The forward-
looking statements contained in this news release represent our judgment as of
the date of this release. Immunex undertakes no obligation to publicly update
any forward-looking statements. An electronic version of this news release --
as well as additional information about Immunex of interest to investors,
customers, future employees and patients -- is available on the Immunex home
page at http://www.immunex.com.
SOURCE Immunex Corporation
 back to top
Related links:
http://www.immunex.com
Company News On-Call:
http://www.prnewswire.com/comp/434644.html
CONTACT:
media, Robin Shapiro, +1-206-389-4040, or
investors, Mark Leahy, +1-206-389-4363, both of Immunex
Corporation
|
